Quantitative correlation between theoretical molecular descriptors and drug-HSA binding affinities for various cox-2 inhibitors

Chemical Biology and Drug Design

Volumn 72, Issue 4, 2008, Pages 297-302

  Seedher, Neelam ^a   Bhatia, Sonu ^a   Singh, Bhupinder ^b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Correlation; Cox 2 inhibitors; HSA binding; Theoretical molecular descriptors

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ETODOLAC; ETORICOXIB; HUMAN SERUM ALBUMIN; MELOXICAM; NIMESULIDE; PARECOXIB; ROFECOXIB; VALDECOXIB;

ARTICLE; BINDING AFFINITY; CORRELATION ANALYSIS; DRUG PROTEIN BINDING; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

BINDING SITES; CYCLOOXYGENASE 2 INHIBITORS; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SERUM ALBUMIN;

EID: 52649165685     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2008.00711.x     Document Type: Article

References (18)

1. Basak S. (1987) Use of molecular complexity indices in predictive pharmacology and toxicology. Med Sci Res 15 : 605 609.
2. Jonnson M.A., Basak S.C., Maggiora G. (1988) A characterization of molecular similarity methods for property prediction. Math Comput Model 11 : 630 634.
3. Khedkar S.A., Malde A.K., Coutinho E.C., Srivastava S. (2007) Pharmacophore modeling in drug discovery and development: an overview. Med Chem 3 : 187 197.
4. Gupta S.P., Babu M.S., Sowmya S. (1998) A quantitative structure-activity relationship study on some sulfolanes and arylthiomethanes acting as HIV-1 protease inhibitors. Bioorg Med Chem 11 : 2185 2192.
5. Basak S.C., Harriss D.K., Magnuson V.R. (1984) Comparative study of lipophilicity versus topological molecular descriptors in biological correlations. J Pharm Sci 73 : 429 437.
6. Mao H., Hajduk P.J., Crag R., Bell R., Borre T., Fesik S.W. (2001) Rational design of diflunisal analogues with reduced affinity for human serum albumin. J Am Chem Soc 123 : 10429 10435.
7. Nandave M.D., Ojha S.K., Arya D.S. (2006) Should selective cox-2 inhibitors be used more? Indian J Pharm Sci 68 : 281 285.
8. Marwali M.L., Mehta J.L. (2006) Cox-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studies. Thromb Haemost 96 : 407 412.
9. Seedher N., Bhatia S. (2005) Mechanism of interaction of the non-steroidal anti-inflammatory drugs meloxicam and nimesulide with serum albumin. J Pharm Biomed Anal 39 : 257 262.
10. Seedher N., Bhatia S. (2006) Reversible binding of celecoxib and valdecoxib with human serum albumin using fluorescence spectroscopic technique. Pharmacol Res 54 : 77 84.
11. Seedher N., Bhatia S. (2006) Interaction of non-steroidal anti-inflammatory drugs, etoricoxib and parecoxib sodium, with human serum albumin studied by fluorescence spectroscopy. Drug Metabol Drug Interact 22 : 25 45.
12. Mignot I., Presle N., Lapicque F., Monot C., Dropsy R., Netter P. (1996) Albumin binding sites for etodolac enantiomers. Chirality 8 : 271 280.
13. Topliss J.G., Edwards R.P. (1979) Chance factors in studies of quantitative structure-activity relationships. J Med Chem 22 : 1238 1244.
14. Lien E.J., Wang P.H. (1980) Lipophilicity, molecular weight and drug action: reexamination of parabolic and bilinear models. J Pharm Sci 69 : 648 650.
15. 1-acid glycoprotein and human serum albumin. Int J Pharm 59 : 137 143.
16. Seedher N. (2000) Quantitative structure protein binding relationships for some non-steroidal anti-inflammatory drugs. Indian J Pharm Sci 62 : 402 404.
17. Zlotos G., Bucker A., KInzig-Schippers M., Sorgel F., Holzgrabe U. (1997) Plasma protein binding of gyrase inhibitors. J Pharm Sci 87 : 215 220.
18. Zhivkova Z.D., Russeva V.N. (2003) Thermodynamic characterization of the binding process of sulindac to human serum albumin. Arzneimittelforschung 53 : 53 56.